Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Clare Y Slaney

Showing results (21-30 of 40) with videos related to

Pageof 4
Sort By:
Cancer Research|September 17, 2014
BMP4 inhibits breast cancer metastasis by blocking myeloid-derived suppressor cell activityYuan Cao, Clare Y Slaney, Bradley N Bidwell, et al.
Oncoimmunology|September 17, 2020
Primary and metastatic breast tumors cross-talk to influence immunotherapy responsesAmanda J Oliver, Simon P Keam, Bianca von Scheidt, et al.
Oncotarget|February 1, 2018
An ultrastructural investigation of tumors undergoing regression mediated by immunotherapyJennifer A Westwood, Sarah Ellis, Jill Danne, et al.
Cancers|December 24, 2021
Enhancing Adoptive Cell Transfer with Combination BRAF-MEK and CDK4/6 Inhibitors in MelanomaPeter Kar Han Lau, Carleen Cullinane, Susan Jackson, et al.
Clinical & Translational Immunology|July 25, 2020
Enhancing chimeric antigen receptor T-cell immunotherapy against cancer using a nanoemulsion-based vaccine targeting cross-presenting dendritic cellsJack D Chan, Bianca von Scheidt, Bijun Zeng, et al.
Plos One|September 4, 2015
Embryonic Lethality in Homozygous Human Her-2 Transgenic Mice Due to Disruption of the Pds5b GeneCarmen S M Yong, Janelle Sharkey, Belinda Duscio, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 27, 2019
Enterotoxins can support CAR T cells against solid tumorsBianca von Scheidt, Minyu Wang, Amanda J Oliver, et al.
Clinical & Translational Immunology|August 25, 2025
Optimised modular anti-FLAG CAR T cells for solid tumor therapyXiaomeng Zhang, Rachel Xu, Dmitry Zorin, et al.
Clinical & Translational Immunology|November 27, 2019
Tissue-specific tumor microenvironments influence responses to immunotherapiesAmanda J Oliver, Ashleigh S Davey, Simon P Keam, et al.
Clinical & Translational Immunology|December 2, 2024
Choice of activation protocol impacts the yield and quality of CAR T cell product, particularly with older individualsPalak H Mehta, Gemma S Trollope, Patrick Leung, et al.
Pageof 4

Showing results (21-30 of 40) with videos related to

Sort By:
Pageof 4
Cancer Research|September 17, 2014
BMP4 inhibits breast cancer metastasis by blocking myeloid-derived suppressor cell activityYuan Cao, Clare Y Slaney, Bradley N Bidwell, et al.
Oncoimmunology|September 17, 2020
Primary and metastatic breast tumors cross-talk to influence immunotherapy responsesAmanda J Oliver, Simon P Keam, Bianca von Scheidt, et al.
Oncotarget|February 1, 2018
An ultrastructural investigation of tumors undergoing regression mediated by immunotherapyJennifer A Westwood, Sarah Ellis, Jill Danne, et al.
Cancers|December 24, 2021
Enhancing Adoptive Cell Transfer with Combination BRAF-MEK and CDK4/6 Inhibitors in MelanomaPeter Kar Han Lau, Carleen Cullinane, Susan Jackson, et al.
Clinical & Translational Immunology|July 25, 2020
Enhancing chimeric antigen receptor T-cell immunotherapy against cancer using a nanoemulsion-based vaccine targeting cross-presenting dendritic cellsJack D Chan, Bianca von Scheidt, Bijun Zeng, et al.
Plos One|September 4, 2015
Embryonic Lethality in Homozygous Human Her-2 Transgenic Mice Due to Disruption of the Pds5b GeneCarmen S M Yong, Janelle Sharkey, Belinda Duscio, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 27, 2019
Enterotoxins can support CAR T cells against solid tumorsBianca von Scheidt, Minyu Wang, Amanda J Oliver, et al.
Clinical & Translational Immunology|August 25, 2025
Optimised modular anti-FLAG CAR T cells for solid tumor therapyXiaomeng Zhang, Rachel Xu, Dmitry Zorin, et al.
Clinical & Translational Immunology|November 27, 2019
Tissue-specific tumor microenvironments influence responses to immunotherapiesAmanda J Oliver, Ashleigh S Davey, Simon P Keam, et al.
Clinical & Translational Immunology|December 2, 2024
Choice of activation protocol impacts the yield and quality of CAR T cell product, particularly with older individualsPalak H Mehta, Gemma S Trollope, Patrick Leung, et al.
Pageof 4